ArticleScientific reports2026
PGA-TMC/PTMC/nHA composite membrane with synergistic barrier and osteogenic functions for enhanced bone defect regeneration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Balancing mechanical strength, controllability of degradation and bioactivities, remains a significant challenge for absorbable barrier membranes in guided bone regeneration (GBR) for the treatment of bone defects. To overcome these limitations, a novel absorbable synthetic PGA-TMC/PTMC/nHA (PGTTH) barrier membrane was developed using electrospinning technology to prolong barrier duration and promote rapid bone repair. The PGTTH membrane integrates three functional components in a one-step fabrication process: a poly (glycolic acid-co-trimethylene cabonate) (PGA-TMC) copolymer matrix providing mechanical integrity, polytrimethylene carbonate (PTMC) imparting flexibility and a slow, linear degradation profile to ensure long-term structural stability, nano-hydroxyapatite (nHA) delivering bioactive ions to enhance osteogenesis and biomineralization. To systematically evaluate the performance of the PGTTH membrane, mechanical characterization and in vitro degradation tests confirmed that the membrane exhibits appropriate mechanical properties and a slow degradation profile, thereby demonstrating its ability to maintain structural space over an extended period. Furthermore, in vitro and in vivo studies demonstrated that the PGTTH membrane significantly promotes cell adhesion, proliferation, and osteogenic differentiation. In conclusion, this study not only presents a promising GBR barrier membrane material with potential for clinical application, but also offers a new design strategy and experimental basis for developing absorbable membranes that combine excellent barrier functionality with osteoinductive capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.